|
|
|
GMO GLOBAL ASSET
ALLOCATION SERIES FUND
|
|
Summary Prospectus
August 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
Share Class:
|
|
Class R4
|
|
Class R5
|
|
Class R6
|
|
|
|
|
Ticker:
|
|
|
|
|
|
GATRX
|
|
|
|
|
Before you invest, you may want to review the Funds prospectus, which contains more information
about the Fund and its risks. You can find the Funds prospectus, statement of additional information and other information about the Fund online at http://dc.gmo.com. You can also get this information at no cost by calling
877-466-7778,
by sending an email request to DCFundProspectus@gmo.com, or by contacting your financial intermediary. The Funds prospectus and statement of additional
information, both dated August 31, 2013, as supplemented, are incorporated by reference into this summary prospectus.
Investment objective
Total return greater than that of its benchmark, the GMO Global Asset Allocation Index, an internally maintained index computed by GMO, consisting of 65% MSCI ACWI and 35% Barclays U.S. Aggregate Index.
Fees and expenses
The tables below describe the fees and expenses that you may pay for each class of shares if you buy and hold shares of the Fund.
Shareholder fees
|
|
|
|
|
|
|
|
|
|
|
Fees paid directly
from your investment
|
|
|
Fees paid by the Fund
|
|
Purchase premium (as a percentage of amount invested)
|
|
|
0
|
|
|
|
0.11
|
%
1
|
Redemption fee (as a percentage of amount redeemed)
|
|
|
0
|
|
|
|
0.11
|
%
1
|
Annual Fund operating expenses
2
(expenses that you pay each year as a percentage of the value
of your investment)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class R4
|
|
|
Class R5
|
|
|
Class R6
|
|
Management fee
3
|
|
|
0.00
|
%
|
|
|
0.00
|
%
|
|
|
0.00
|
%
|
Distribution and service (12b-1) fee
4
|
|
|
0.25
|
%
|
|
|
0.10
|
%
|
|
|
None
|
|
Other expenses
5
|
|
|
0.05
|
%
|
|
|
0.05
|
%
|
|
|
0.05
|
%
|
Acquired fund fees and expenses
6
|
|
|
0.59
|
%
|
|
|
0.59
|
%
|
|
|
0.59
|
%
|
Total annual fund operating expenses
|
|
|
0.89
|
%
|
|
|
0.74
|
%
|
|
|
0.64
|
%
|
Expense reimbursement
7
|
|
|
(0.00
|
%)
|
|
|
(0.00
|
%)
|
|
|
(0.00
|
%)
|
Total annual fund operating expenses after expense reimbursement
|
|
|
0.89
|
%
|
|
|
0.74
|
%
|
|
|
0.64
|
%
|
1
These amounts are
paid to and retained by GMO Global Asset Allocation Fund (GAAF), the underlying fund in which the Fund invests, to help offset estimated portfolio transaction and other related costs.
2
The information in this table and in the Example
below reflects the expenses of both the Fund and GAAF.
3
Neither the Fund nor GAAF charges a management fee, but each indirectly bears the management fees of the underlying funds in which GAAF invests.
4
Distribution and service (12b-1) fees are paid to
financial intermediaries for providing sub-transfer agency, recordkeeping, and other administrative services.
5
Other expenses include administration fees of 0.05%.
6
These indirect expenses include interest expense that may be incurred by certain underlying funds and also include, to the
extent applicable, purchase premiums and redemption fees (transaction fees) charged by certain underlying funds. Net fees and expenses of underlying funds (before addition of interest expense and transaction fees), indirect interest
expense, and indirect transaction fees were approximately 0.52%, less than 0.01%, and 0.07%, respectively.
7
Grantham, Mayo, Van Otterloo & Co. LLC (the Manager or GMO) has contractually agreed to reimburse the Fund for state registration fees to the
extent that they are borne by the Fund. These reimbursements will continue through at least August 31, 2014, and may not be terminated prior to this date without the action or consent of the Funds Board of Trustees.
Example
This example is intended to
help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The example assumes that you invest $10,000 in the Fund for the time periods indicated. The example also assumes that your investment has a 5%
return each year and that the Funds operating expenses remain the same as those shown in the table. The one year amounts shown reflect expense reimbursements and all amounts shown include the expenses of both GAAF and the Fund. Although your
actual costs may be higher or lower, based on these assumptions your costs would be:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If you sell your shares
|
|
|
If you do not sell your shares
|
|
|
|
1 Year*
|
|
|
3 Years
|
|
|
5 Years
|
|
|
10 Years
|
|
|
1 Year*
|
|
|
3 Years
|
|
|
5 Years
|
|
|
10 Years
|
|
Class R4
|
|
$
|
113
|
|
|
$
|
345
|
|
|
$
|
596
|
|
|
$
|
1,315
|
|
|
$
|
102
|
|
|
$
|
333
|
|
|
$
|
583
|
|
|
$
|
1,299
|
|
Class R5
|
|
$
|
98
|
|
|
$
|
298
|
|
|
$
|
516
|
|
|
$
|
1,141
|
|
|
$
|
86
|
|
|
$
|
286
|
|
|
$
|
502
|
|
|
$
|
1,125
|
|
Class R6
|
|
$
|
88
|
|
|
$
|
267
|
|
|
$
|
461
|
|
|
$
|
1,023
|
|
|
$
|
76
|
|
|
$
|
255
|
|
|
$
|
448
|
|
|
$
|
1,007
|
|
* After reimbursement
GMO GLOBAL ASSET ALLOCATION SERIES FUND
Portfolio turnover
The Fund pays transaction costs when it buys and sells securities. A higher portfolio turnover rate may result in higher transaction costs and, when Fund
shares are held in a taxable account, higher taxes. These costs, which are not reflected in Annual Fund operating expenses or in the Example, affect the Funds performance. During the Funds initial fiscal period (from July 31, 2012
to April 30, 2013), the Funds portfolio turnover rate (excluding short-term investments) was 6% of the average value of its portfolio.
Principal investment strategies
The Fund invests substantially all of its assets in GMO Global Asset Allocation Fund (GAAF), which invests primarily in shares of other funds managed by GMO (GMO Funds). The
Funds investment objective and principal investment strategies, therefore, are substantially similar to those of GAAF. References to the Fund may refer to actions undertaken by the Fund or GAAF. The Funds investment adviser, GMO, is also
the investment adviser to GAAF.
The Fund is a fund of funds and invests primarily in shares of other GMO Funds, which may include GMO Funds
that invest in international and emerging market equity securities (collectively, the GMO International Equity Funds), GMO Funds that invest in global equity securities (collectively, the GMO Global Equity Funds), GMO Funds
that invest in U.S. equity securities (collectively, the GMO U.S. Equity Funds), GMO Funds that invest in fixed income securities (collectively, the GMO Fixed Income Funds), GMO Alpha Only Fund, GMO Alternative Asset
Opportunity Fund, GMO Debt Opportunities Fund, GMO High Quality Short-Duration Bond Fund, GMO Special Situations Fund, GMO World Opportunity Overlay Fund, and GMO U.S. Flexible Equities Fund (collectively, the underlying Funds). In
addition, the Fund may invest in securities (particularly asset-backed securities) and derivatives directly.
The Fund is permitted to invest
in non-U.S. and U.S. equity investments (which may include emerging country equities, both growth and value style equities and equities of any market capitalization), U.S. and non-U.S. fixed income securities (including asset-backed securities and
other fixed income securities of any credit quality and having any maturity or duration), commodities and, from time to time, other alternative asset classes. The term equity investments refers to direct and indirect investments in
common stocks and other stock-related securities, such as preferred stocks, convertible securities, depositary receipts, and exchange-traded equity real estate investment trusts (REITs) and income trusts.
The Manager uses multi-year forecasts of returns and risk among asset classes (e.g., non-U.S. equity, U.S. equity, emerging country equity, emerging
country debt, U.S. fixed income, non-U.S. fixed income and commodities) to select the underlying Funds in which the Fund invests and to decide how much to invest in each. An important component of those forecasts is the expectation that valuation
reversion ultimately drives market returns. The Manager changes the Funds holdings of underlying Funds in response to changes in its investment outlook and market valuations and may use redemptions or purchases of Fund shares to rebalance the
Funds investments. Under normal circumstances, the Manager intends to invest not more than 85% of the Funds assets in the GMO U.S. Equity Funds, GMO International Equity Funds and GMO Global Equity Funds. The factors considered and
investment methods used by the Manager can change over time.
The Fund also may invest in GMO U.S. Treasury Fund, another GMO Fund, and
unaffiliated money market funds.
The Fund may hold cash, cash equivalents, and/or U.S. government securities to manage cash inflows and
outflows as a result of shareholder purchases and redemptions.
Principal risks of investing in the Fund
The value of the Funds shares changes with the value of the Funds investments. Many factors can affect this value, and you may lose money by
investing in the Fund. References to investments include those held directly by the Fund and indirectly through the Funds investments in the underlying Funds. Because the Fund invests substantially all of its assets in GAAF, the most
significant risks of investing in the Fund are the risks to which the Fund is exposed through GAAF, which include those outlined in the following brief summary of principal risks. Some of the underlying Funds of GAAF are
non-diversified
investment companies
under the Investment Company Act of 1940, as amended, and therefore a decline in the market price of a particular security held by those underlying Funds may affect their performance more than if they were diversified
investment companies. In addition to the risks to which the Fund is exposed through its investment in GAAF, the Fund is subject to the risk that cash flows into or out of the Fund will cause its performance to be worse than the performance of GAAF.
|
|
Market Risk Equities
The market prices of equities may decline due to factors affecting the issuing companies,
their industries, or the economy and equity markets generally. If an underlying Fund purchases equities at a discount from their value as determined by the Manager, the Fund runs the risk that the market prices of these investments will not
appreciate or will decline for a variety of reasons, one of which may be the Managers overestimation of the value of those investments. An underlying Fund also may purchase equities that typically trade at higher multiples of current earnings
than other securities, and the market prices of these investments often are more sensitive to changes in future earnings expectations than the market prices of equities trading at lower multiples. Declines in stock market prices generally are likely
to reduce the net asset value of the Funds shares.
|
|
|
Management and Operational Risk
The Fund runs the risk that GMOs investment techniques will fail to produce desired
results. The Funds portfolio managers may use quantitative analyses and models, and any imperfections, errors, or limitations in those analyses and models could affect the ability of the portfolio managers to implement the Funds
strategies. By necessity, these analyses and models make simplifying assumptions that limit their efficacy. Models that appear to explain prior market data can fail to predict future market events. Further, the data used in models may be inaccurate
and may not include the most recent information about a company or a security. The Fund also runs the risk that GMOs assessment of an investment may be wrong or that deficiencies in GMOs or another service providers internal
systems or controls will cause losses for the Fund or impair Fund operations.
|
|
|
Non-U.S. Investment Risk
The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many
non-U.S. markets are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than in U.S. markets. Non-U.S. portfolio transactions generally involve higher commission rates,
transfer taxes, and custodial costs than similar transactions in the U.S. In addition, the Fund may be subject to non-U.S. taxes, including potentially on a retroactive basis, on (i) capital gains it realizes or dividends or interest it
receives on non-U.S. investments, (ii) transactions in those investments, and (iii) the repatriation of proceeds generated from the sale of those investments. Also, many non-U.S. markets require a license for the Fund to invest directly in
those markets, and the Fund is subject to the risk that it could not invest if its license were terminated or suspended. In some non-U.S. markets, prevailing custody and trade
|
2
GMO GLOBAL ASSET ALLOCATION SERIES FUND
|
settlement practices (e.g., the requirement to pay for securities prior to receipt) expose the Fund to credit and other risks with respect to participating brokers, custodians, clearing banks or
other clearing agents, escrow agents and issuers. Further, adverse changes in investment regulations, capital requirements or exchange controls could adversely affect the value of the Funds investments. These and other risks (e.g.,
nationalization, expropriation or other confiscation of assets of non-U.S. issuers) tend to be greater for investments in companies tied economically to emerging countries, the economies of which tend to be more volatile than the economies of
developed countries.
|
|
|
Market Risk Fixed Income Investments
The market price of a fixed income investment can decline due to a number
of market-related factors, including rising interest rates and widening credit spreads, or decreased liquidity stemming from the markets uncertainty about the value of a fixed income investment (or class of fixed income investments).
|
|
|
Market Risk Asset-Backed Securities
The market price of fixed income investments with complex structures, such
as asset-backed securities, can decline due to a number of factors, including market uncertainty about their credit quality and the reliability of their payment streams. Payment streams associated with asset-backed securities held by the Fund depend
on many factors (e.g., the cash flow generated by the assets backing the securities, the deal structure, the credit worthiness of any credit-support provider, and the reliability of various other service providers with access to the payment stream),
and a problem in any one of these areas can lead to a reduction in the payment stream the Manager expected the Fund to receive at the time the Fund purchased the asset-backed security.
|
|
|
Options Risk
The market price of options written by an underlying Fund will be affected by many factors, including changes in
the market price or dividend rates of underlying securities (or in the case of indices, the securities comprising such indices); changes in interest rates or exchange rates; changes in the actual or perceived volatility of the relevant stock market
and underlying securities; and the time remaining before an options expiration.
|
|
|
Liquidity Risk
Low trading volume, lack of a market maker, large position size, or legal restrictions may limit or prevent the
Fund or an underlying Fund from selling particular securities or unwinding derivative positions at desirable prices.
|
|
|
Derivatives Risk
The use of derivatives involves the risk that their value may not move as expected relative to the value of
the underlying assets, rates, or indices. Derivatives also present other risks, including market risk, liquidity risk, currency risk, credit risk, and counterparty risk.
|
|
|
Fund of Funds Risk
The Fund is indirectly exposed to all of the risks of an investment in GAAF and the underlying Funds in
which it invests, including the risk that GAAF and those underlying Funds will not perform as expected. Because the Fund bears the fees and expenses of GAAF and the underlying Funds in which it invests, a reallocation of GAAFs investments to
underlying Funds with higher fees or expenses will increase the Funds total expenses. The fees and expenses associated with an investment in the Fund are less predictable than those associated with an investment in funds that charge a fixed
management fee.
|
|
|
Smaller Company Risk
Smaller companies may have limited product lines, markets, or financial resources, may lack the
competitive strength of larger companies, or may lack managers with experience or depend on a few key employees. The securities of small- and mid-cap companies often are less widely held and trade less frequently and in lesser quantities, and their
market prices often fluctuate more, than the securities of companies with larger market capitalizations.
|
|
|
Natural Resources Risk
To the extent an underlying Fund concentrates its assets in the natural resources sector, the value
of its portfolio is subject to factors affecting the natural resources industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
|
|
|
Commodities Risk
Commodities prices can be extremely volatile and exposure to commodities can cause the net asset value of the
Funds shares to decline and fluctuate in a rapid and unpredictable manner.
|
|
|
Currency Risk
Fluctuations in exchange rates can adversely affect the market value of non-U.S. currency holdings and
investments denominated in non-U.S. currencies. In addition, hedging a non-U.S. currency can have a negative effect on performance if the U.S. dollar declines in value relative to that currency.
|
|
|
Leveraging Risk
The use of reverse repurchase agreements and other derivatives and securities lending creates leverage.
Leverage increases the Funds losses when the value of its investments (including derivatives) declines.
|
|
|
Credit Risk
The Fund runs the risk that the issuer or guarantor of a fixed income investment or the obligor of an obligation
underlying an asset-backed security will be unable or unwilling to satisfy its obligation to pay principal and interest or otherwise to honor its obligations in a timely manner. The market price of a fixed income investment will normally decline as
a result of the issuers, guarantors, or obligors failure to meet its payment obligations. Below investment grade securities have speculative characteristics, and changes in economic conditions or other circumstances are more likely
to impair the capacity of issuers to make principal and interest payments than is the case with issuers of investment grade securities.
|
|
|
Counterparty Risk
The Fund runs the risk that the counterparty to a derivatives contract, a clearing member used by the Fund to
hold a cleared derivatives contract, or a borrower of the Funds securities will be unable or unwilling to make timely settlement payments, return the Funds margin or otherwise honor its obligations.
|
|
|
Real Estate Risk
To the extent an underlying Fund concentrates its assets in real estate-related investments, the value of its
portfolio is subject to factors affecting the real estate industry and may fluctuate more than the value of a portfolio that consists of securities of companies in a broader range of industries.
|
|
|
Market Disruption and Geopolitical Risk
Geopolitical and other events may disrupt securities markets and adversely affect
global economies and markets. Those events, as well as other changes in non-U.S. and U.S. economic and political conditions, could adversely affect the value of the Funds investments.
|
|
|
Short Sales Risk
The Fund runs the risk that an underlying Funds loss on a short sale of securities that the underlying
Fund does not own is unlimited.
|
|
|
Focused Investment Risk
Focusing investments in countries, regions, sectors, companies, or industries with high positive
correlations to one another creates more risk than if the Funds investments were less correlated.
|
|
|
Large Shareholder Risk
To the extent that a large number of shares of the Fund is held by a single shareholder (e.g., an
institutional investor or financial intermediary), the Fund is subject to the risk that a redemption by that shareholder of all or a large portion of its Fund shares will disrupt the Funds operations.
|
3
GMO GLOBAL ASSET ALLOCATION SERIES FUND
Performance
The bar chart and table below provide some indication of the risks of investing in the Fund by showing changes in the Funds annual total returns from year to year for the periods indicated and by
comparing the Funds average annual total returns for different calendar periods with those of broad-based indices and the Funds benchmark (which is a composite index computed by the Manager). The Fund commenced operations on
July 31, 2012. Returns prior to the date the Fund commenced operations are those of GAAF (Class III shares), adjusted to reflect the estimated gross operating expenses (on a percentage basis) that were expected to be borne by shareholders of
each class of shares of the Fund as of the commencement of the Funds operations. The effect of purchase premiums and redemption fees paid by the Fund to GAAF are not reflected in the bar chart or table below for portions of the periods prior
to the date on which the Fund commenced operations. If the effect of these payments were reflected, returns for periods prior to the date on which the Fund commenced operations would be less than those shown. After-tax returns are calculated using
the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on your tax situation and may differ from those shown. After-tax returns shown are not
relevant if you are tax-exempt or if you hold your Fund shares through tax-deferred arrangements (such as a 401(k) plan or individual retirement account). After-tax returns are shown for Class R4 shares only; after-tax returns for other classes will
vary. Past performance (before and after taxes) is not an indication of future performance.
Annual Total Returns
/Class R4 Shares
Years Ending December 31
Highest Quarter: 14.19% (2Q2003)
Lowest Quarter: 9.55% (4Q2008)
Year-to-Date (as of 6/30/13): 3.20%
Average Annual Total Returns
Periods Ending December 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Year
|
|
|
5 Years
|
|
|
10 Years
|
|
|
Inception
|
|
Class R4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6/28/96
|
*
|
Return Before
Taxes
|
|
|
9.77%
|
|
|
|
3.15%
|
|
|
|
8.36%
|
|
|
|
7.36%
|
|
Return After Taxes on
Distributions
|
|
|
9.19%
|
|
|
|
1.82%
|
|
|
|
6.94%
|
|
|
|
5.48%
|
|
Return After Taxes on
Distributions and Sale of Fund Shares
|
|
|
6.79%
|
|
|
|
2.03%
|
|
|
|
6.69%
|
|
|
|
5.42%
|
|
Class R5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return Before
Taxes
|
|
|
9.93%
|
|
|
|
3.31%
|
|
|
|
8.53%
|
|
|
|
7.53%
|
|
Class R6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return Before
Taxes
|
|
|
10.05%
|
|
|
|
3.41%
|
|
|
|
8.64%
|
|
|
|
7.64%
|
|
MSCI ACWI
(returns reflect no
deduction for fees or expenses, but are net of withholding tax on dividend reinvestments)
|
|
|
16.13%
|
|
|
|
1.16%
|
|
|
|
8.11%
|
|
|
|
5.39%
|
|
Barclays U.S. Aggregate Index
(reflects no deduction for fees, expenses, or taxes)
|
|
|
4.22%
|
|
|
|
5.95%
|
|
|
|
5.18%
|
|
|
|
6.31%
|
|
GMO Global Asset Allocation Index
(Fund benchmark)
|
|
|
12.07%
|
|
|
|
1.82%
|
|
|
|
6.78%
|
|
|
|
5.09%
|
|
* Inception date for GAAF. GAAF commenced operations on June 28, 1996 with two classes of shares Class I
shares and Class II shares. No class II shares were outstanding as of October 16, 1996. Class III shares were first issued on October 22, 1996. Class I shares converted to Class III shares on January 9, 1998. Class III performance
information presented in the table represents Class II performance information June 28, 1996 to October 16, 1996, Class I performance from October 16, 1996 to October 21, 1996, and Class III performance thereafter.
Management of the Fund
Investment Adviser: Grantham, Mayo, Van Otterloo & Co. LLC
Investment
Division and Senior Members of GMO primarily responsible for portfolio management of the Fund:
|
|
|
|
|
Investment Division
|
|
Senior Member (Length of Service with Fund)
|
|
Title
|
Asset Allocation
|
|
Ben Inker (since the Funds inception)
|
|
Co-Head, Asset Allocation Division, GMO
|
Asset Allocation
|
|
Sam Wilderman (since 2012)
|
|
Co-Head, Asset Allocation Division, GMO
|
Purchase and sale of Fund shares
In general, shareholders of record may purchase and redeem shares of the Fund on days when the New York Stock Exchange is open for business. Investors purchasing shares of the Fund through an intermediary
(e.g., retirement plan participants purchasing through a retirement plan administrator) should contact their intermediary to purchase and redeem shares of the Fund. There is no minimum initial investment for retirement plan participants and similar
investors purchasing shares of the Fund through an intermediary. The minimum initial investment for shareholders of record that establish an omnibus account with the Fund is $10 million, but that amount may be waived or reduced at the discretion of
GMO.
Tax information
The
Fund expects to distribute net investment income and net realized capital gains, if any, to shareholders. These distributions generally are taxable to shareholders whose Fund shares are held in a taxable account as ordinary income and/or capital
gain. Retirement plan participants investing in the Fund through a tax-qualified retirement plan generally will not be subject to tax on these Fund distributions so long as their Fund shares remain in the qualified plan. Retirement plan
participants, however, may be taxed upon withdrawals from their qualified plan. Retirement plan participants and others investing in the Fund through another type of tax-advantaged plan or account should consult with their tax adviser and plan
administrator or other designated financial intermediary for information regarding the specific U.S. federal income tax consequences to them of receiving Fund distributions and their Fund investment more generally.
Financial intermediary compensation
If
you purchase shares of the Fund through a broker-dealer, agent, or other financial intermediary (such as a bank), the Fund and GMO may pay that party for services relating to Fund shares. These payments may create a conflict of interest by
influencing the broker-dealer or other intermediary and your salesperson to recommend the Fund over another investment. Ask your salesperson or visit your financial intermediarys website for more information.
4
Vu1 (CE) (USOTC:VUOC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Vu1 (CE) (USOTC:VUOC)
Historical Stock Chart
From Aug 2023 to Aug 2024